Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

43.99USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$43.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
184,058
52-wk High
$74.75
52-wk Low
$32.19

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 7.30 -1.956
Jun '18 2.42 -1.403
Mar '18 0.00 -1.054
FY 2017 Dec '17 0.00 -1.603
Sep '17 0.00 -0.894
Jun '17 0.00 -0.817
Mar '17 0.00 -0.763
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 9 17.01 25.50 14.00 10.38
Quarter Ending Jun-19 9 22.90 30.10 16.20 17.10
Year Ending Dec-19 11 117.16 134.82 100.00 125.90
Earnings (per share)
Quarter Ending Mar-19 7 -0.73 -0.39 -1.03 -0.59
Quarter Ending Jun-19 7 -0.58 -0.20 -0.83 -0.44
Year Ending Dec-19 9 -1.62 -0.46 -2.35 -0.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 147.99 49.93
P/E Low - Last 5 Yrs. -- 47.78 24.27
Beta 1.06 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 10.34 10.16 5.27
Price to Tangible Book (MRQ) 10.34 13.82 6.78
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions -- 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.05 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 5.88
Sales - 5 Yr. Growth Rate -- 22.77 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.74 75.88 47.26
EPS (TTM) vs TTM 1 Yr. Ago -2.87 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 152.98 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 22.45 3.43 3.08
LT Debt to Equity (MRQ) 66.85 18.73 11.39
Total Debt to Equity (MRQ) 66.85 31.43 16.13
Interest Coverage (TTM) -39.77 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.79
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.24 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -- -175.21 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.84 8.61
Net Profit Margin (TTM) -- -181.94 3.31
Net Profit Margin - 5 Yr. Avg. -- -137.24 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,651,352 844,195,039
Net Income/Employee (TTM) -1,130,063 652,648 100,058,867
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.02 6.45 11.08
Return on Assets - 5 Yr. Avg. -50.91 5.52 12.21
Return on Investment (TTM) -51.22 8.99 14.48
Return on Investment - 5 Yr. Avg. -55.60 6.86 15.88
Return on Equity (TTM) -128.08 10.14 15.99
Return on Equity - 5 Yr. Avg. -343.74 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -17.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aerie Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.61 -12.73 17 99
13 Week -5.73 -10.32 39 95
26 Week 18.71 9.69 68 98
52 Week 30.29 10.43 69 72
YTD 39.10 22.16 69 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 253
Total Shares Held: 49,760,389
3 Mo. Net Change: -56,996
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 14
# Reduced Positions: 10
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.